A decade of Science Translational Medicine

Elazer R Edelman; Garret A FitzGerald

doi:10.1126/scitranslmed.aax4327

A decade of Science Translational Medicine

Sci Transl Med. 2019 Apr 24;11(489):eaax4327. doi: 10.1126/scitranslmed.aax4327.

Authors

Elazer R Edelman^{1

2}, Garret A FitzGerald^{1

2}

Affiliations

¹ Elazer R. Edelman is co-Chief Scientific Advisor of Science Translational Medicine. He is the Director and Edward J. Poitras Professor, Institute for Medical Engineering and Science at MIT, Cambridge, MA 02139, Professor of Medicine at Harvard Medical School, and Senior Attending Physician in the Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Email: ere@mit.edu.
² Garret A. FitzGerald is co-Chief Scientific Advisor of Science Translational Medicine. He is Professor of Medicine and Pharmacology, McNeil Professor in Translational Medicine and Therapeutics, Director, Institute for Translational Medicine & Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: garret@upenn.edu.

PMID: 31019024
DOI: 10.1126/scitranslmed.aax4327

Abstract

In this Editorial, co-Chief Scientific Advisors of Science Translational Medicine, Elazer Edelman and Garret FitzGerald, discuss challenges and opportunities for the next decade of translational research.

Publication types

Editorial

MeSH terms

Biomedical Research
Humans
Translational Research, Biomedical*